Day One Biopharmaceuticals (DAWN) Current Leases (2022 - 2025)
Historic Current Leases for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Q3 2025 value amounting to $161000.0.
- Day One Biopharmaceuticals' Current Leases rose 10909.09% to $161000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $161000.0, marking a year-over-year increase of 10909.09%. This contributed to the annual value of $10000.0 for FY2024, which is 9754.9% down from last year.
- Per Day One Biopharmaceuticals' latest filing, its Current Leases stood at $161000.0 for Q3 2025, which was up 10909.09% from $153000.0 recorded in Q2 2025.
- Over the past 5 years, Day One Biopharmaceuticals' Current Leases peaked at $462000.0 during Q3 2022, and registered a low of $10000.0 during Q4 2024.
- In the last 4 years, Day One Biopharmaceuticals' Current Leases had a median value of $300000.0 in 2024 and averaged $273866.7.
- As far as peak fluctuations go, Day One Biopharmaceuticals' Current Leases surged by 14385.96% in 2023, and later plummeted by 9754.9% in 2024.
- Day One Biopharmaceuticals' Current Leases (Quarter) stood at $405000.0 in 2022, then increased by 0.74% to $408000.0 in 2023, then plummeted by 97.55% to $10000.0 in 2024, then surged by 1510.0% to $161000.0 in 2025.
- Its last three reported values are $161000.0 in Q3 2025, $153000.0 for Q2 2025, and $62000.0 during Q1 2025.